Our Views Articles, views and insights from the ADAMAS team. Enhancing Good Pharmacovigilance Practice with ADAMAS Consulting ADAMAS Consulting is proud to announce an upcoming course in collaboration with the Research Quality Association (RQA), titled "A Systems Approach to Good... DIA 2024 Global Annual Meeting | San Diego, CA ADAMAS looks forward to attending the upcoming DIA Global Annual Meeting 2024 that will take place in San Diego, CA from 16-20 June.... Come and meet ADAMAS Consulting at the RQA European QA Conference, Belfast ADAMAS is thrilled to announce our presence at the RQA 2023 International QA Conference, taking place from the 1st to the 3rd of... Computer Software Assurance (CSA): Why the Change and What Does it Mean? At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER)... Annex 1 Revisions: What are the Changes and Whom will they Affect? The EU has released a draft version of Annex 1. Expected to be implemented either later this year (2022) or early next year,... Why Is Data Integrity Important When Transferring Data in a Clinical Trial? This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”.... Load More Loading More... You’ve reached the end of the list
Enhancing Good Pharmacovigilance Practice with ADAMAS Consulting ADAMAS Consulting is proud to announce an upcoming course in collaboration with the Research Quality Association (RQA), titled "A Systems Approach to Good...
DIA 2024 Global Annual Meeting | San Diego, CA ADAMAS looks forward to attending the upcoming DIA Global Annual Meeting 2024 that will take place in San Diego, CA from 16-20 June....
Come and meet ADAMAS Consulting at the RQA European QA Conference, Belfast ADAMAS is thrilled to announce our presence at the RQA 2023 International QA Conference, taking place from the 1st to the 3rd of...
Computer Software Assurance (CSA): Why the Change and What Does it Mean? At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER)...
Annex 1 Revisions: What are the Changes and Whom will they Affect? The EU has released a draft version of Annex 1. Expected to be implemented either later this year (2022) or early next year,...
Why Is Data Integrity Important When Transferring Data in a Clinical Trial? This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”....